Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[18F]fluoro-17β-oestradiol PET

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 1, 2011, Pages 37-45

  Tsujikawa, Tetsuya ^a   Yoshida, Yoshio ^a   Kiyono, Yasushi ^a   Kurokawa, Tetsuji ^a   Kudo, Takashi ^a   Fujibayashi, Yasuhisa ^a   Kotsuji, Fumikazu ^a   Okazawa, Hidehiko ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Endometrial carcinoma; FDG; Fluoro oestradiol; Oestrogen receptor; PET

Indexed keywords

16ALPHA ESTRADIOL F 18; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; KI 67 ANTIGEN; PROGESTERONE RECEPTOR B; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG UPTAKE; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; UTERUS SURGERY;

BIOLOGICAL TRANSPORT; ENDOMETRIAL NEOPLASMS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; FLUORODEOXYGLUCOSE F18; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 79551590711     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1589-8     Document Type: Article

References (37)

1. E Utaaker OE Iversen E Skaarland 1987 The distribution and prognostic implications of steroid receptors in endometrial carcinomas Gynecol Oncol 28 89 100 1:STN:280:DyaL1c%2FgsF2hsg%3D%3D 10.1016/S0090-8258(87)80013-6 3653774
2. DN Danforth Jr 1992 Hormone receptors in malignancy Crit Rev Oncol Hematol 12 91 149 10.1016/1040-8428(92)90086-6 1317180
3. JA Gustafsson 1999 Estrogen receptor β - a new dimension in estrogen mechanism of action J Endocrinol 163 379 383 1:CAS:528:DC%2BD3cXks1agtw%3D%3D 10.1677/joe.0.1630379 10588810
4. S Ogawa S Inoue T Watanabe H Hiroi A Orimo T Hosoi, et al. 1998 The complete primary structure of human estrogen receptor beta (hER β) and its heterodimerization with ER α in vivo and in vitro Biochem Biophys Res Commun 243 122 126 1:CAS:528:DyaK1cXpsVWruw%3D%3D 10.1006/bbrc.1997.7893 9473491 (Pubitemid 28414201)
5. V Jongen J Briët R de Jong K ten Hoor M Boezen A van der Zee, et al. 2009 Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer Gynecol Oncol 112 537 542 1:CAS:528:DC%2BD1MXisVOiu7o%3D 10.1016/j.ygyno.2008.10.032 19108875
6. LP Pertschuk S Masood J Simone JG Feldman RG Fruchter CA Axiotis, et al. 1996 Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival Gynecol Oncol 63 28 33 1:STN:280: DyaK2s%2FltlOmsg%3D%3D 10.1006/gyno.1996.0273 8898164 (Pubitemid 26337961)
7. WT Creasman 1993 Prognostic significance of hormone receptors in endometrial cancer Cancer 71 1467 1470 1:STN:280:DyaK3s7mtFakug%3D%3D 8431882
8. M Singh RJ Zaino VJ Filiaci KK Leslie 2007 Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study Gynecol Oncol 106 325 333 1:CAS:528:DC%2BD2sXot1ygurc%3D 10.1016/j.ygyno.2007.03.042 17532033 (Pubitemid 47087930)
9. 18F]fluoro- 17β-estradiol uptake in metastatic breast carcinoma J Nucl Med 32 1526 1531 1:STN:280:DyaK3Mzjt1Kquw%3D%3D 1869973
10. F Dehdashti JE Mortimer BA Siegel LK Griffeth TJ Bonasera MJ Fusselman, et al. 1995 Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays J Nucl Med 36 1766 1774 1:STN:280:DyaK28%2FgslKhsQ%3D%3D 7562040
11. F Dehdashti FL Flanagan JE Mortimer JA Katzenellenbogen MJ Welch BA Siegel 1999 Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy Eur J Nucl Med 26 51 56 1:CAS:528:DyaK1cXnvFSis70%3D 10.1007/s002590050359 9933662 (Pubitemid 29137739)
12. HM Linden SA Stekhova JM Link JR Gralow RB Livingston GK Ellis, et al. 2006 Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer J Clin Oncol 24 2793 2799 1:CAS:528:DC%2BD28XntV2hu7c%3D 10.1200/JCO.2005.04.3810 16682724 (Pubitemid 46630578)
13. T Tsujikawa Y Yoshida T Mori T Kurokawa Y Fujibayashi F Kotsuji, et al. 2008 Uterine tumors: pathophysiologic imaging with 16α-[18F]fluoro- 17β-estradiol and 18F fluorodeoxyglucose PET-initial experience Radiology 248 599 605 10.1148/radiol.2482071379 18539894
14. 18F-FDG PET J Nucl Med 50 1598 1604 1:CAS:528:DC%2BD1MXhtlehsbjJ 10.2967/jnumed.108.060145 19759112
15. 18F]fluoro-17β-estradiol J Med Chem 48 6366 6378 1:CAS:528:DC%2BD2MXpvFSnu7s%3D 10.1021/jm050121f 16190762 (Pubitemid 41428988)
16. S Pecorelli 2009 Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynaecol Obstet 105 103 104 10.1016/j.ijgo.2009.02.012 19367689
17. DO Kiesewetter MR Kilbourn SW Landvatter DF Heiman JA Katzenellenbogen MJ Welch 1984 Preparation of four fluorine-18-labeled estrogens and their selective uptakes in target tissues of immature rats J Nucl Med 25 1212 1221 1:CAS:528:DyaL2MXktVSitw%3D%3D 6092569
18. 18F]fluorodeoxyglucose synthesizer Nucl Med Biol 33 281 286 1:CAS:528:DC%2BD28Xis1ehtr8%3D 10.1016/j.nucmedbio.2005.11.002 16546684
19. I Mylonas U Jeschke N Shabani C Kuhn S Kunze D Dian, et al. 2007 Steroid receptors ERα, ERβ, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium Histol Histopathol 22 169 176 1:CAS:528:DC%2BD2sXjt1Khu7w%3D 17149689
20. N Shabani C Kuhn S Kunze S Schulze D Mayr D Dian, et al. 2007 Prognostic significance of oestrogen receptor alpha (ERα) and beta (ERβ), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas Eur J Cancer 43 2434 2444 1:CAS:528:DC%2BD2sXht1akur7P 10.1016/j.ejca.2007.08.014 17911007 (Pubitemid 350001248)
21. OM Conneely JP Lydon F De Mayo BW O'Malley 2000 Reproductive functions of the progesterone receptor J Soc Gynecol Investig 7 S25 S32 1:CAS:528: DC%2BD3cXht1OhsL0%3D 10.1016/S1071-5576(99)00062-3 10732326
22. K Fukuda M Mori M Uchiyama K Iwai T Iwasaka H Sugimori 1998 Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma Gynecol Oncol 69 220 225 1:CAS:528:DyaK1cXksV2qs7w%3D 10.1006/gyno.1998.5023 9648591 (Pubitemid 28289963)
23. PG Rose 1996 Endometrial carcinoma N Engl J Med 335 640 649 1:STN:280:DyaK28zitVCqsQ%3D%3D 10.1056/NEJM199608293350907 8692240 (Pubitemid 26277956)
24. P Kastner A Krust B Turcotte U Stropp L Tora H Gronemeyer, et al. 1990 Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B EMBO J 9 1603 1614 1:CAS:528:DyaK3cXmtVGkuro%3D 2328727
25. H Gronemeyer 1991 Transcription activation by estrogen and progesterone receptors Annu Rev Genet 25 89 123 1:CAS:528:DyaK38Xhs1Kgt7s%3D 10.1146/annurev.ge.25.120191.000513 1667464
26. S Basu W Chen J Tchou A Mavi T Cermik B Czerniecki, et al. 2008 Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization Cancer 112 995 1000 1:CAS:528:DC%2BD1cXjs1eqsLo%3D 10.1002/cncr.23226 18098228 (Pubitemid 351304582)
27. 18F-fluoroestradiol J Nucl Med 49 367 374 10.2967/jnumed.107.047506 18287268 (Pubitemid 351355201)
28. DA Mankoff F Dehdashti 2009 Imaging tumor phenotype: 1 plus 1 is more than 2 J Nucl Med 50 1567 1569 10.2967/jnumed.108.061044 19759107
29. A Behrooz F Ismail-Beigi 1999 Stimulation of glucose transport by hypoxia: signals and mechanisms News Physiol Sci 14 105 110 1:CAS:528: DyaK1MXksVajtbk%3D 11390832
30. M Stoner B Saville M Wormke D Dean R Burghardt S Safe 2002 Hypoxia induces proteasome-dependent degradation of estrogen receptor α in ZR-75 breast cancer cells Mol Endocrinol 16 2231 2242 1:CAS:528:DC%2BD38XnsFKmu78%3D 10.1210/me.2001-0347 12351689 (Pubitemid 35155536)
31. C Cooper GY Liu YL Niu S Santos LC Murphy PH Watson 2004 Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor α in human breast carcinoma Clin Cancer Res 10 8720 8727 1:CAS:528:DC%2BD2cXhtFGjsLzN 10.1158/1078-0432.CCR-04-1235 15623657 (Pubitemid 40053441)
32. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression J Nucl Med 45 22 29 1:CAS:528: DC%2BD2cXht1artLc%3D 14734665
33. ML Helin MJ Helle HJ Helin JJ Isola 1989 Proliferative activity and steroid receptors determined by immunohistochemistry in adjacent frozen sections of 102 breast carcinomas Arch Pathol Lab Med 113 854 857 1:STN:280: DyaL1MzjsVGltA%3D%3D 2667495
34. JJ Sirvent M Santafé MT Salvadó T Alvaro A Raventós J Palacios 1994 Hormonal receptors, cell proliferation fraction (Ki-67) and c-erbB-2 amplification in breast cancer. Relationship between differentiation degree and axillary lymph node metastases Histol Histopathol 9 563 570 1:STN:280:DyaK2M%2Fnt1eltg%3D%3D 7526910
35. EV Gaffney TL Venz-Williamson G Hutchinson PJ Biggs KM Nelson 1996 Relationship of standardized mitotic indices to other prognostic factors in breast cancer Arch Pathol Lab Med 120 473 477 8639051
36. F Takama T Kanuma D Wang I Kagami H Mizunuma 2001 Oestrogen receptor β expression and depth of myometrial invasion in human endometrial cancer Br J Cancer 84 545 549 1:CAS:528:DC%2BD3MXhvVarurk%3D 10.1054/bjoc.2000.1589 11207052 (Pubitemid 32215884)
37. J Fujimoto H Sakaguchi I Aoki H Toyoki T Tamaya 2002 Clinical implications of the expression of estrogen receptor-α and -β in primary and metastatic lesions of uterine endometrial cancers Oncology 62 269 277 1:CAS:528:DC%2BD38Xlt1ylsL4%3D 10.1159/000059575 12065875 (Pubitemid 34639061)